The move builds on the ABPI’s agenda for change set out a year ago to strengthen its capacity to engage with and on behalf of key partners and its members.
For the BIA, the move represents an opportunity to enhance the UK’s competitive position in life sciences, expand collaborative relationships for our members and extend the UK bioscience community.
Nigel Gaymond, Chief Executive of the BIA, said:
“The UK has exceptional strengths in life sciences. Establishing a central venue where those with an interest in life sciences can access the combined expertise of the BIA and ABPI will enable us to highlight more effectively all that the UK has to offer. We are looking forward to welcoming our members as well as visitors from around the globe, and demonstrating why the UK truly is one of the world’s leading life sciences destinations.”
Dr Richard Barker, Director General of the ABPI, said:
“Since the establishment of the Office of Life Sciences, our two organisations have been working more collaboratively, and we are already seeing the benefits. Feedback from Government and other key stakeholders following the creation of LifeSciencesUK was very positive. Our organisations have been able to operate more strategically, and more effectively, by representing the life sciences sector with one voice, alongside the ABHI and BIVDA. This move strengthens a joint determination that the UK remain a great place to invest and do business in life sciences.”
The two trade bodies will remain as independent organisations with separate offices on a shared floor of the Victoria Street premises. This closer proximity will facilitate more effective joint working on cross-industry issues.
For further information, please contact:
ABPI: Bron Madson, Head of Media Affairs, 020 7747 1410; email@example.com
BIA: Robert Winder, Communications Manager, 020 7565 7193; mobile 07825 942 934 or firstname.lastname@example.org
Notes to editors
The new address for the ABPI and BIA will be:
7th Floor, Southside, 105 Victoria Street, London SW1E 6QT
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry (ABPI) is the trade association for the research-based pharmaceutical industry in the UK, representing companies both small and large.
Our member companies research, develop, manufacture and supply more than 80 per cent of the branded medicines prescribed through the National Health Service (NHS). For further information visit: www.abpi.org.uk
Established in 1989, the BioIndustry Association (BIA) exists to encourage and promote a financially sound and thriving bioscience sector within the UK economy and concentrates its efforts on emerging enterprise and the related interests of companies with whom such enterprise trades.
With over 250 members, the BIA supports a wide range of sectors, majoring on the human health benefits of the technology and represents the interests of these innovative companies to a broad section of stakeholders from patient groups to politicians, advancing its members interests both within the UK and internationally to create a healthy UK bioscience sector which benefits society. For further information, please go to: www.bioindustry.org